Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 17 studies | 30% ± 12% | |
macrophage | 13 studies | 29% ± 12% | |
monocyte | 8 studies | 23% ± 7% | |
non-classical monocyte | 7 studies | 32% ± 10% | |
myeloid cell | 7 studies | 26% ± 12% | |
epithelial cell | 7 studies | 37% ± 8% | |
basal cell | 7 studies | 26% ± 7% | |
regulatory T cell | 6 studies | 20% ± 5% | |
alveolar macrophage | 5 studies | 24% ± 6% | |
ciliated cell | 5 studies | 22% ± 7% | |
secretory cell | 5 studies | 27% ± 6% | |
goblet cell | 5 studies | 25% ± 4% | |
CD4-positive, alpha-beta T cell | 4 studies | 22% ± 3% | |
conventional dendritic cell | 4 studies | 38% ± 7% | |
transit amplifying cell | 4 studies | 22% ± 7% | |
CD8-positive, alpha-beta T cell | 4 studies | 20% ± 2% | |
club cell | 3 studies | 24% ± 2% | |
fibroblast | 3 studies | 29% ± 8% | |
mononuclear phagocyte | 3 studies | 23% ± 2% | |
enterocyte | 3 studies | 21% ± 5% | |
luminal cell of prostate epithelium | 3 studies | 35% ± 7% | |
dendritic cell | 3 studies | 33% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5180.93 | 1444 / 1445 | 99% | 41.17 | 182 / 183 |
breast | 100% | 3272.18 | 459 / 459 | 99% | 51.63 | 1110 / 1118 |
intestine | 100% | 7960.67 | 966 / 966 | 99% | 67.45 | 523 / 527 |
thymus | 100% | 2346.95 | 651 / 653 | 99% | 35.43 | 600 / 605 |
liver | 100% | 3312.89 | 225 / 226 | 99% | 36.79 | 403 / 406 |
lung | 100% | 4745.10 | 577 / 578 | 99% | 44.74 | 1143 / 1155 |
kidney | 100% | 2696.47 | 89 / 89 | 98% | 42.45 | 883 / 901 |
prostate | 100% | 2864.13 | 244 / 245 | 98% | 38.52 | 494 / 502 |
stomach | 100% | 3632.08 | 359 / 359 | 98% | 48.47 | 280 / 286 |
bladder | 100% | 3656.48 | 21 / 21 | 95% | 46.85 | 477 / 504 |
pancreas | 95% | 1838.33 | 311 / 328 | 98% | 45.61 | 174 / 178 |
uterus | 91% | 1468.15 | 155 / 170 | 90% | 47.69 | 412 / 459 |
skin | 100% | 3585.06 | 1808 / 1809 | 68% | 15.60 | 319 / 472 |
adrenal gland | 97% | 1819.09 | 250 / 258 | 19% | 3.01 | 43 / 230 |
ovary | 40% | 449.62 | 72 / 180 | 72% | 12.61 | 311 / 430 |
adipose | 100% | 3658.96 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 106.84 | 29 / 29 |
muscle | 100% | 5875.95 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3849.92 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3871.07 | 1332 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 7981.24 | 925 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 56.39 | 44 / 45 |
heart | 85% | 1065.65 | 735 / 861 | 0% | 0 | 0 / 0 |
brain | 13% | 137.98 | 343 / 2642 | 35% | 7.09 | 250 / 705 |
eye | 0% | 0 | 0 / 0 | 34% | 4.96 | 27 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070221 | Biological process | sulfide oxidation, using sulfide:quinone oxidoreductase |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0070224 | Molecular function | sulfide:quinone oxidoreductase activity |
GO_0071949 | Molecular function | FAD binding |
GO_0106436 | Molecular function | glutathione-dependent sulfide quinone oxidoreductase activity |
GO_0048038 | Molecular function | quinone binding |
Gene name | SQOR |
Protein name | Sulfide quinone oxidoreductase Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.8) (Sulfide dehydrogenase-like) (Sulfide quinone oxidoreductase) |
Synonyms | SQRDL CGI-44 |
Description | FUNCTION: Catalyzes the oxidation of hydrogen sulfide with the help of a quinone, such as ubiquinone-10, giving rise to thiosulfate and ultimately to sulfane (molecular sulfur) atoms. Requires an additional electron acceptor; can use sulfite, sulfide or cyanide (in vitro) . It is believed the in vivo electron acceptor is glutathione . . |
Accessions | ENST00000565997.1 ENST00000260324.12 H3BUD7 H3BMS6 ENST00000561493.5 H3BV36 H3BT21 A0A1B0GXB4 ENST00000566934.1 ENST00000568606.5 H3BNP9 Q9Y6N5 ENST00000561735.5 ENST00000563296.1 ENST00000565227.1 |